Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for Cognitive Impairment in Elderly Focal Epilepsy
NCT07193277Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Sep 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of butylphthalide in cognitive impairment, sponsored by The First Affiliated Hospital of Wenzhou Medical University. Started Sep 2025; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT07193277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07193277.